Literature DB >> 6286102

Neutralization of feline leukemia virus with feline antisera to leukocyte alloantigens.

T H Lee, M Essex, F de Noronha, J Azocar.   

Abstract

The possibility that normal cellular antigens might serve as targets for antibody neutralization of the feline leukemia virus was investigated. Xenospecific antiserum directed to normal feline cells was shown to inactivate feline leukemia virus grown in fibroblasts. Cat antisera to normal feline leukocyte alloantigens were then prepared, after which persistent viremia was induced in the donor cats. Such alloantisera neutralized virus taken from plasma of the appropriate cat but did not neutralize virus from a different cat. The virus neutralization was dependent on the presence of complement. These results indicate that alloantigens are present at the virus surface and raise the possibility that such antigens may play a role in the natural immune response directed to retrovirus infections.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6286102

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  6 in total

1.  The presence of host-derived HLA-DR1 on human immunodeficiency virus type 1 increases viral infectivity.

Authors:  R Cantin; J F Fortin; G Lamontagne; M Tremblay
Journal:  J Virol       Date:  1997-03       Impact factor: 5.103

2.  Effect of the cytoplasmic domain of the simian immunodeficiency virus envelope protein on incorporation of heterologous envelope proteins and sensitivity to neutralization.

Authors:  A N Vzorov; R W Compans
Journal:  J Virol       Date:  2000-09       Impact factor: 5.103

3.  Restricted neutralization of divergent human T-lymphotropic virus type III isolates by antibodies to the major envelope glycoprotein.

Authors:  T J Matthews; A J Langlois; W G Robey; N T Chang; R C Gallo; P J Fischinger; D P Bolognesi
Journal:  Proc Natl Acad Sci U S A       Date:  1986-12       Impact factor: 11.205

Review 4.  Feline leukemia/sarcoma viruses and immunodeficiency.

Authors:  J Rojko; M Essex; Z Trainin
Journal:  Adv Vet Sci Comp Med       Date:  1988

Review 5.  The antiviral activity of antibodies in vitro and in vivo.

Authors:  P W Parren; D R Burton
Journal:  Adv Immunol       Date:  2001       Impact factor: 3.543

6.  Evaluation of the human T-cell leukemia virus type I seropositivity of blood donors by the particle agglutination inhibition test.

Authors:  K W Kwon; H Ikeda; M Yano; S Sekiguchi
Journal:  Jpn J Cancer Res       Date:  1989-09
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.